ML20141A987
| ML20141A987 | |
| Person / Time | |
|---|---|
| Issue date: | 10/17/1985 |
| From: | Adam W NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION III) |
| To: | |
| Shared Package | |
| ML20141A992 | List: |
| References | |
| 13-15892-01, 13-15892-1, NUDOCS 8602240087 | |
| Download: ML20141A987 (3) | |
Text
_ _
%.Ti~3*ATATr1*LTrri4T1*1Tr1T1%% AT'sW1CETM1 TAW %TMJ[A%TANgq-N:c ro,ma4 1
3 i
~
W ste '
U.S. NUCLEAR CEGULATORY COMMISSION PACE.
OF PAGES l
h f
MATIIRIALS LICENSE Amendment No. 01 l
Pursuant t,o the Atomic Energy Act of 1954;as amended. the Energy Reorganization Act of 1974 (Public Law 93-438),:.nd Title 10, y Code of Federal Regulations, Chapter 1, Parts 30,31,32,33,34,35,40 and 70, and in reliance on statements and representations g heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct,
[
y source, and special nuclear material designated below; to use such material for the purpose (s) and at the place (s) designated below;to I
h deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This I
h license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is I
j subject to all applicable rules, regulations and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any l
conditions specified below, g
U#* *
- J In accordance with letter dated i
November 30, 1984 I
h 1. King's Daughters' Hospital
- 3. Ucense number 13-15892-01 is amended in j
its entirety to read as followst i
h2. 112 Presbyterian Avenue
- { 7 "kr7ti N
' 4. bxp I
Madison, IN 47250 e
October 31, 1990 I
I ch I
l
%y
- 5. Docket or,7 030-14051 I
J,!
g Reference No.
i m
Ih; 6. Byproduct, source,and/or
- 7. Chemical and/or physical U. Maximum amount that licensee I
special nuclear material form my possess at any one time
'I h
//
gder thislicense x
I A.AnybyproductmaterII' radiopharm t
1
. Aa necessary for 1
s J
listed in Groups I i ted7iiiro h M
uses authorized I
and II of Schedule
=and II of Sch I,
O in Subite= 9.A hQ MiO4TFR 35kJctiot't&35110g M'
/<
k l
f Section 35.100 of }""
p 10 CFR 35 g
\\ D [
- ;lis" # f /8h, I
(f)
,,Any rn ' Ij
'in flh,'
$.2 curies I
B. Any byproduct material
]h listed in Group III
{ Group, [
Io'f $cheduisd,
Schedule A Section @Y of each byproduct I
l i
tSaction J$.I
'I Q
material authorized I
i
{0 CFR35" 's r'
in Subitem 6.B I
35.100 of 10 CFR 35 j
$p C. Any io'didevthat has41/
Q@
C. 200 mil 11 curies l
i W/i N
/
]
C. Iodine-131
]
been manufactured, h 3
abeled, package, and
'ingrilgated,Ja rdance I
witt a specific license l
issued pursuant to i
1 Section 32.72 of 10 CFR i
Part 32 or a specific I
license issued to a I
8602240087 851017 manu acturer by an
]
1 REG 3 LIC30 Agreement State pursuant
]
13-15892-01 PDR to equivalent State i
i j
regulations l
I
- 9. Authorized Use I
I A. Any diagnostic procedure listed in Groups I and II of Schedule A, Section 35.100 I
)
of Title 10, Code of Federal Regulations.
l l
B. Preparation and use of radiopharmaceuticals for any diagnostic procedure listed in I
Group III of Schedule A, Section 35.100 of Title 10, Code of Federal Regulations.
l i
e I
l C. For treatment of hyperthyroidism and cardiac dysfunction.
[
f I
ggh0 COPY i
i
- - _ _ _ _ _ _ _ _ - - s m s- _ _ r rs _,.r.r rs s m r,.r r m s _ _ n.r_ _ _ _ _ _ _ J M ?).L C!
KITITi~1Ti'M X1%1W1T1WIWI'ETIM TITEITi'iTITAM TATA'ATAM T i NRC F org f 4 A U.S. NUCLE A3 CEGULATORY COMMISSION rAct 2
or 3
PA*ES
]'
D ss) '
i twenie rumber MATERIALS LICENSE 13-18692-01 1'
SUPPLEMENTARY SHEET a!
030-14051 1
T:
Amendment No. 01 JlI 1
CONDITIONS U
f 10.
Licensed material shall be used only at the licensee's facilities located at 1'.
112 Presbyterian Avenue, Madison, Indiana.
l 1
11.
The licensee shall comply with the provisions of Title 10, Chapter 1, Code of Federal 1
Regulations, Part 19, " Notices, Instructions and Reports to Workers; Inspections" and f
Part 20, "Standarda for Protection Against Radiation."
1'] 12.
Licensed material shall be used by, or under the supervision of, Thomas D.
Breitweiser,M.D.orMelvinJ.Skilds,M7D.{
]
pys Ui tf 13.
For a period not to exceed"shty (60) days in any calendar year, a visiting physician 1,
is authorized to use licerise*d material for human use u' rider the terms of this license, f
providedthevisitingphysician:
'O (a) Has the prior r en permission of the hospital's-Adm strator and its Medical I
Isotopes Coc:mi tie, and -
[
A Is specifica1'ly named as' a. user onTNuclea [ Regulatory b. mission lic 1
4.!/
\\
g
[;
(b) authorizingpumanuse,and Q
k T ~2
$ ^2 T
(c) Performs onl,y those procedures % 'Jor which s
g sJspec'ificalg% authorized by a i
1 Nuclear Regulatory Dommission4! cense Q df*h
{UQR
,f y;hf f I
3, The licensee shall eaintaiiffor 'inspe tito 1pkoi-tje711cens g
elthe Conse'ission opies of the vritten jl permission specified'in Subitcai;i(ad ' * !an specified in Subitems (b) and (cNabove.8tThese recer
'khall e mainta) for five (5) years from the time the licen'see grants itFpdraiission]iinder SublNm (a) above.
u 1
V pg ytp 3
j 1 14.
Licensed material shall beensed in accordance with t visions of 1
Section 35.14(b)(c)(e) and (f) of Title 10, Code of F eral Regulations.
15.
The licensee is authorized to ho d i iti eIma rial with a physical half-life of 1.
less than 65 days for decay-in-storage before disposal in ordinary trash provided:
l' 1l A.
Radioactive waste to be disposed of in this manner shall be held for decay a f
minimum of ten (10) half-lives.
J B.
Prior to disposal as normal waste, radioactive waste shall be monitored to f;
determine that its radioactivity cannot be distinguished from background with
]
];
typical low-level laboratory survey instruments. All radiation labels will be lj removed or obliterated.
lh l
C.
Generator columns shall be segregated so that they may be monitored separately to ensure decay to background levels prior to disposal.
1 l!
lj 1*
1 1
i 1
l COPY J<--Mid)QFr.3DiDirkasX.iWimammiss9FXXJrJussir#Jr#mzTim 'u0sUsusimammusumimmius
[TA14TM2bEIT$N_E11DISMNN_NNNTM*EETTAEAYEAEA l NIC Form 374A U.S. NUCLE AR CE;ULATORY COMMISSION race 3
or 3
racts.
4 I'; W
)
Licina number h'
MATERIALS LICENSE 13-18692-01 l
SUPPLEMENTARY SHEET gf 030-14051 l'
Il l
Amendment No. 01 lI fl Except as specifically provided otherwise by this license, the licensee shall possess 16.
and use licensed material described in Items 6, 7, and 8 of this license in g!
accordance with statements, representations, and procedures contained in application dated March 28, 1979; letters dated November 30, 1984 and July 1, 1985; and ALARA q!I Program dated August 15, 1980. The Nuclear Regulatory Commission's regulations shall I!
govern the licensee's statements in applications or letters, unless the statements f
are more restrictive than the regulations.
I!
Ii, g-
{
pp REGy i
e
%O 1:
l' T
/
(/
Ig (l
Lu)
?G
,,L I
4 O
1
/~
e I,
q h Y fw'a
@m!
O g
p\\
~
I b
i s6%
M( fpj/
b g
a w/ (~s {;F' w*f,P h~
w Q1 ls I
!'\\
$thjj J
t J-O
/,0 h
w{
j S g-g &
d' l'
ll l'
I' ll N.
I' N,
l' f
For the U.S. Nuclear Regulatory Commission II I
1:
1 OCT 17 ;g95 1
original S1gud f{D:te By William J. Adam, Ph.D.
j g'
Materials Licensing Section, Region III l
II COPY l
g dygyrggKJFMTWv.E1FKE2.WXXXXXJEE/50FXJFJFJEAT'wh>"0FWW"W=r r.Ow rwi--r-Egggjg[ _
- -